GSK Says Russia, Turkey, Other Emerging Markets Lead Sales Decline
This article was originally published in PharmAsia News
Executive Summary
Emerging markets are producing poor pharmaceutical sales, according to GlaxoSmithKline, which reported a decline in earnings for the year’s first quarter, primarily because of low vaccine orders and Middle East unrest.